Ribbon Bio
2 known investors
Ribbon produces cell-free synthetic DNA made without bacteria, avoiding the contamination, delays, and design limits of cloning-based workflows. Its products, including a kit-based on-site synthesis system, target mRNA therapies, vaccine development, cell and gene therapies, protein engineering, and gene editing applications.
BiotechDeep Tech
Investors · 2
Frequently asked questions
- What does Ribbon Bio do?
- Ribbon produces cell-free synthetic DNA made without bacteria, avoiding the contamination, delays, and design limits of cloning-based workflows. Its products, including a kit-based on-site synthesis system, target mRNA therapies, vaccine development, cell and gene therapies, protein engineering, and gene editing applications.
- Who are Ribbon Bio's investors?
- Ribbon Bio's investors include Hadean Ventures, xista science ventures.